The main rate-limiting enzyme for glutamine catabolism, GLS1, is highly expressed in various cancers, including small-cell lung cancer, hepatic carcinoma, and ESCC, with its down-regulation impacting cancer cell proliferation, invasion, and migration [29]. This evidence concerns the gene GLS and esophageal squamous cell carcinoma.